📊 Score Breakdown
Offering Ability
65
Cash Runway
0
Float Risk
50
Warrant Exposure
30
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
34%
📉 Score Deterioration
40%
• Score rose 21 points recently (worsening)
💰 Capital Raise
38%
• Active shelf registration ($100M, 25% of market cap)
• Active ATM program with $100M remaining capacity
📜 Warrant Exercise
15%
• Warrant overhang: 7.5% of shares outstanding
💹 Market Data
Market Cap$397.14M
Shares Outstanding34.35M
Float17.87M
Cash$184.76M
Debt$876.0K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 36.8% shares (2025Q4 vs prior)
72 institutional holders · 31.70M shares
#1
SUVRETTA CAPITAL MANAGEMENT, LLC
11.55M shares
#2
JANUS HENDERSON GROUP PLC
2.91M shares
#3
FRANKLIN RESOURCES INC
2.20M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest2.25M
Days to Cover23.0
% of Float12.6%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Apr 22, 2024
424B3
ATM
Feb 11, 2026
EFFECT
EFFECT
Feb 10, 2026
S-3
SHELF
Jan 30, 2026
4
INSIDER TRANSACTION
Jan 26, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for BNTC
📊 BNTC FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 BNTC Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.